{"doc_id": "33570497", "type of study": "Therapy", "title": "", "abstract": "An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial.\nFollowing the successful scale-up of antiretroviral therapy (ART), the focus is now on ensuring good quality of life (QoL) and sustained viral suppression in people living with HIV.\nThe access to mobile technology in the most burdened countries is increasing rapidly, and therefore, mobile health (mHealth) technologies could be leveraged to improve QoL in people living with HIV.\nHowever, data on the impact of mHealth tools on the QoL in people living with HIV are limited to the evaluation of SMS text messaging; these are infeasible in high-illiteracy settings.\nThe primary and secondary outcomes were to determine the impact of interactive voice response (IVR) technology on Medical Outcomes Study HIV QoL scores and viral suppression at 12 months, respectively.\nWithin the Call for Life study, ART-experienced and ART-na\u00efve people living with HIV commencing ART were randomized (1:1 ratio) to the control (no IVR support) or intervention arm (daily adherence and pre-appointment reminders, health information tips, and option to report symptoms).\nThe software evaluated was Call for Life Uganda, an IVR technology that is based on the Mobile Technology for Community Health open-source software.\nEligibility criteria for participation included access to a phone, fluency in local languages, and provision of consent.\nThe differences in differences (DIDs) were computed, adjusting for baseline HIV RNA and CD4.\nOverall, 600 participants (413 female, 68.8%) were enrolled and followed-up for 12 months.\nIn the intervention arm of 300 participants, 298 (99.3%) opted for IVR and 2 (0.7%) chose SMS text messaging as the mode of receiving reminders and health tips.\nAt 12 months, there was no overall difference in the QoL between the intervention and control arms (DID=0.0; P=.99) or HIV RNA (DID=0.01; P=.94).\nAt 12 months, 124 of the 256 (48.4%) active participants had picked up at least 50% of the calls.\nIn the active intervention participants, high users (received >75% of reminders) had overall higher QoL compared to low users (received <25% of reminders) (92.2 versus 87.8, P=.02).\nSimilarly, high users also had higher QoL scores in the mental health domain (93.1 versus 86.8, P=.008) and better appointment keeping.\nSimilarly, participants with moderate use (51%-75%) had better viral suppression at 12 months (80/94, 85% versus 11/19, 58%, P=.006).\nOverall, there was high uptake and acceptability of the IVR tool.\nWhile we found no overall difference in the QoL and viral suppression between study arms, people living with HIV with higher usage of the tool showed greater improvements in QoL, viral suppression, and appointment keeping.\nWith the declining resources available to HIV programs and the increasing number of people living with HIV accessing ART, IVR technology could be used to support patient care.\nThe tool may be helpful in situations where physical consultations are infeasible, including the current COVID epidemic.\nTRIAL REGISTRATION : ClinicalTrials.gov NCT02953080; https://clinicaltrials.gov/ct2/show/NCT02953080.\n\u00a9Dathan Mirembe Byonanebye, Maria S Nabaggala, Agnes Bwanika Naggirinya, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Noela Owarwo, Eva Laker, Richard Orama, Barbara Castelnuovo, Agnes Kiragga, Rosalind Parkes-Ratanshi. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 11.02.2021.\n", "Evidence Map": {"Enrollment": [{"term": "HIV", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 95}, {"term": "ART-experienced and ART-na\u00efve", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 62}, {"term": "HIV", "negation": "affirmed", "UMLS": {}, "start": 82, "end": 85}, {"term": "ART", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 36}, {"term": "active", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 47}, {"term": "living with HIV", "negation": "negated", "UMLS": {}, "start": 98, "end": 113}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda : Randomized Controlled Trial .", "Evidence Elements": {"Participant": [{"term": "HIV", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 95}], "Intervention": [{"term": "Interactive Voice Response Software", "negation": "affirmed", "UMLS": {}, "start": 3, "end": 38, "has_relation": "N/A"}], "Outcome": [{"term": "Quality of Life", "negation": "affirmed", "UMLS": {}, "start": 54, "end": 69}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "Following the successful scale-up of antiretroviral therapy ( ART ) , the focus is now on ensuring good quality of life ( QoL ) and sustained viral suppression in people living with HIV .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "The access to mobile technology in the most burdened countries is increasing rapidly , and therefore , mobile health ( mHealth ) technologies could be leveraged to improve QoL in people living with HIV .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "However , data on the impact of mHealth tools on the QoL in people living with HIV are limited to the evaluation of SMS text messaging ; these are infeasible in high-illiteracy settings .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "OBJECTIVE", "Text": "The primary and secondary outcomes were to determine the impact of interactive voice response ( IVR ) technology on Medical Outcomes Study HIV QoL scores and viral suppression at 12 months , respectively .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "interactive voice response ( IVR ) technology", "negation": "affirmed", "UMLS": {}, "start": 67, "end": 112, "has_relation": "N/A"}], "Outcome": [{"term": "Medical Outcomes Study HIV QoL scores", "negation": "affirmed", "UMLS": {}, "start": 116, "end": 153}, {"term": "viral suppression", "negation": "affirmed", "UMLS": {}, "start": 158, "end": 175}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "Within the Call for Life study , ART-experienced and ART-na\u00efve people living with HIV commencing ART were randomized ( 1:1 ratio ) to the control ( no IVR support ) or intervention arm ( daily adherence and pre-appointment reminders , health information tips , and option to report symptoms ) .", "Evidence Elements": {"Participant": [{"term": "ART-experienced and ART-na\u00efve", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 62}, {"term": "HIV", "negation": "affirmed", "UMLS": {}, "start": 82, "end": 85}, {"term": "ART", "negation": "affirmed", "UMLS": {}, "start": 33, "end": 36}], "Intervention": [{"term": "control ( no IVR support )", "negation": "affirmed", "UMLS": {}, "start": 138, "end": 164, "has_relation": "N/A"}, {"term": "intervention", "negation": "negated", "UMLS": {}, "start": 168, "end": 180, "has_procedure": [{"text": "intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 12}], "has_relation": "N/A"}], "Outcome": [{"term": "daily adherence", "negation": "negated", "UMLS": {}, "start": 187, "end": 202}, {"term": "pre-appointment reminders", "negation": "negated", "UMLS": {}, "start": 207, "end": 232}, {"term": "health", "negation": "negated", "UMLS": {}, "start": 235, "end": 241}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The software evaluated was Call for Life Uganda , an IVR technology that is based on the Mobile Technology for Community Health open-source software .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "Eligibility criteria for participation included access to a phone , fluency in local languages , and provision of consent .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The differences in differences ( DIDs ) were computed , adjusting for baseline HIV RNA and CD4 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "differences in differences ( DIDs )", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 39}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Overall , 600 participants ( 413 female , 68.8 % ) were enrolled and followed-up for 12 months .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "In the intervention arm of 300 participants , 298 ( 99.3 % ) opted for IVR and 2 ( 0.7 % ) chose SMS text messaging as the mode of receiving reminders and health tips .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "intervention", "negation": "affirmed", "UMLS": {}, "start": 7, "end": 19, "has_procedure": [{"text": "intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 12}], "has_relation": "N/A"}, {"term": "SMS text messaging", "negation": "affirmed", "UMLS": {}, "start": 97, "end": 115, "has_activity": [{"text": "sms", "maps_to": "C3178909:sms", "start": 0, "end": 3}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": [{"term": "298 ( 99.3 % )", "negation": "affirmed", "UMLS": {}, "start": 46, "end": 60}, {"term": "2 ( 0.7 % )", "negation": "affirmed", "UMLS": {}, "start": 79, "end": 90}]}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "At 12 months , there was no overall difference in the QoL between the intervention and control arms ( DID = 0.0 ; P =.99 ) or HIV RNA ( DID = 0.01 ; P =.94 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "intervention", "negation": "negated", "UMLS": {}, "start": 70, "end": 82, "has_procedure": [{"text": "intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 12}], "has_relation": "N/A"}, {"term": "control", "negation": "negated", "UMLS": {}, "start": 87, "end": 94, "has_relation": "N/A"}], "Outcome": [{"term": "QoL", "negation": "negated", "UMLS": {}, "start": 54, "end": 57}], "Observation": [{"term": "overall difference", "negation": "negated", "UMLS": {}, "start": 28, "end": 46}], "Count": []}, "Evidence Propositions": [{"Intervention": [{"term": "intervention", "has_procedure": [{"text": "intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 12}], "has_relation": "N/A"}, {"term": "control", "has_relation": "N/A"}], "Observation": "overall difference", "Outcome": "QoL", "Count": ""}]}, {"Section": "RESULTS", "Text": "At 12 months , 124 of the 256 ( 48.4 % ) active participants had picked up at least 50 % of the calls .", "Evidence Elements": {"Participant": [{"term": "active", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 47}], "Intervention": [], "Outcome": [{"term": "least", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 83}], "Observation": [], "Count": [{"term": "124", "negation": "affirmed", "UMLS": {}, "start": 15, "end": 18}, {"term": "( 48.4 % )", "negation": "affirmed", "UMLS": {}, "start": 30, "end": 40}]}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "In the active intervention participants , high users ( received > 75 % of reminders ) had overall higher QoL compared to low users ( received < 25 % of reminders ) ( 92.2 versus 87.8 , P = .02 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "active intervention", "negation": "affirmed", "UMLS": {}, "start": 7, "end": 26, "has_procedure": [{"text": "active intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 19}], "has_relation": "N/A"}, {"term": "high users", "negation": "affirmed", "UMLS": {}, "start": 42, "end": 52, "has_relation": "N/A"}, {"term": "75 %", "negation": "affirmed", "UMLS": {}, "start": 66, "end": 70, "has_relation": "N/A"}, {"term": "low users", "negation": "affirmed", "UMLS": {}, "start": 121, "end": 130, "has_relation": "N/A"}], "Outcome": [{"term": "QoL", "negation": "affirmed", "UMLS": {}, "start": 105, "end": 108}], "Observation": [{"term": "overall higher", "negation": "affirmed", "UMLS": {}, "start": 90, "end": 104}], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Similarly , high users also had higher QoL scores in the mental health domain ( 93.1 versus 86.8 , P = .008 ) and better appointment keeping .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "high users", "negation": "affirmed", "UMLS": {}, "start": 12, "end": 22, "has_relation": "N/A"}], "Outcome": [{"term": "QoL scores in the mental health domain", "negation": "affirmed", "UMLS": {}, "start": 39, "end": 77}], "Observation": [{"term": "higher", "negation": "affirmed", "UMLS": {}, "start": 32, "end": 38}, {"term": "93.1", "negation": "affirmed", "UMLS": {}, "start": 80, "end": 84}, {"term": "86.8", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 96}], "Count": []}, "Evidence Propositions": [{"Intervention": [], "Observation": "higher", "Outcome": "", "Count": ""}]}, {"Section": "RESULTS", "Text": "Similarly , participants with moderate use ( 51 %-75 % ) had better viral suppression at 12 months ( 80 / 94,85 % versus 11 / 19,58 % , P = .006 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "moderate use", "negation": "affirmed", "UMLS": {}, "start": 30, "end": 42, "has_relation": "N/A"}], "Outcome": [{"term": "viral suppression", "negation": "affirmed", "UMLS": {}, "start": 68, "end": 85}], "Observation": [{"term": "better", "negation": "affirmed", "UMLS": {}, "start": 61, "end": 67}], "Count": [{"term": "51 %-75 %", "negation": "affirmed", "UMLS": {}, "start": 45, "end": 54}, {"term": "94,85 %", "negation": "affirmed", "UMLS": {}, "start": 106, "end": 113}]}, "Evidence Propositions": [{"Intervention": [], "Observation": "better", "Outcome": "", "Count": ""}]}, {"Section": "CONCLUSIONS", "Text": "Overall , there was high uptake and acceptability of the IVR tool .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "IVR", "negation": "affirmed", "UMLS": {}, "start": 57, "end": 60, "has_relation": "N/A"}], "Outcome": [{"term": "uptake", "negation": "affirmed", "UMLS": {}, "start": 25, "end": 31}, {"term": "acceptability", "negation": "affirmed", "UMLS": {}, "start": 36, "end": 49}], "Observation": [{"term": "high", "negation": "affirmed", "UMLS": {}, "start": 20, "end": 24}], "Count": []}, "Evidence Propositions": []}, {"Section": "CONCLUSIONS", "Text": "While we found no overall difference in the QoL and viral suppression between study arms , people living with HIV with higher usage of the tool showed greater improvements in QoL , viral suppression , and appointment keeping .", "Evidence Elements": {"Participant": [{"term": "living with HIV", "negation": "negated", "UMLS": {}, "start": 98, "end": 113}], "Intervention": [{"term": "between study arms", "negation": "negated", "UMLS": {}, "start": 70, "end": 88, "has_procedure": [{"text": "study", "maps_to": "C0947630:study", "start": 8, "end": 13}], "has_relation": "N/A"}, {"term": "higher usage of the tool", "negation": "negated", "UMLS": {}, "start": 119, "end": 143, "has_relation": "N/A"}], "Outcome": [{"term": "QoL", "negation": "negated", "UMLS": {}, "start": 44, "end": 47}, {"term": "viral suppression", "negation": "negated", "UMLS": {}, "start": 52, "end": 69}, {"term": "QoL", "negation": "negated", "UMLS": {}, "start": 44, "end": 47}, {"term": "viral suppression", "negation": "negated", "UMLS": {}, "start": 52, "end": 69}], "Observation": [{"term": "overall difference", "negation": "negated", "UMLS": {}, "start": 18, "end": 36}, {"term": "greater improvements", "negation": "negated", "UMLS": {}, "start": 151, "end": 171}], "Count": []}, "Evidence Propositions": [{"Intervention": [], "Observation": "overall difference", "Outcome": "QoL", "Count": ""}, {"Intervention": [], "Observation": "overall difference", "Outcome": "viral suppression", "Count": ""}, {"Intervention": [], "Observation": "overall difference", "Outcome": "viral suppression", "Count": ""}, {"Intervention": [{"term": "higher usage of the tool", "has_relation": "N/A"}], "Observation": "greater improvements", "Outcome": "QoL", "Count": ""}, {"Intervention": [{"term": "higher usage of the tool", "has_relation": "N/A"}], "Observation": "greater improvements", "Outcome": "viral suppression", "Count": ""}]}, {"Section": "CONCLUSIONS", "Text": "With the declining resources available to HIV programs and the increasing number of people living with HIV accessing ART , IVR technology could be used to support patient care .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "CONCLUSIONS", "Text": "The tool may be helpful in situations where physical consultations are infeasible , including the current COVID epidemic .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "TRIAL REGISTRATION : ClinicalTrials.gov NCT02953080 ; https:/ / clinicaltrials.gov / ct2 / show / NCT02953080 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "\u00a9Dathan Mirembe Byonanebye, Maria S Nabaggala, Agnes Bwanika Naggirinya, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Noela Owarwo, Eva Laker, Richard Orama, Barbara Castelnuovo, Agnes Kiragga, Rosalind Parkes-Ratanshi . Originally published in JMIR mHealth and uHealth ( http:/ / mhealth . jmir.org ) , 11.02.2021 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}